Global Pharmaceutical Industry Analysis September 21 2009 Dibakar Mitra (P08017) I Manoj Joshi (B08026) Table of Contents EXECUTIVE SUMMARY 3 INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP
Premium Pharmaceutical industry
STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing
The Pharmaceutical Industry “The word medicine is derived from the Latin ars medicine‚ meaning the art of healing.” Medicine is the art and science of healing as practiced by physicians and similar professionals and encompasses all sciences related to it. It is the applied science or practice of the diagnosis‚ treatment and preventions of diseases. It is a variety of health care practices involved in to maintain and restore health by preventing and treatment of different sickness in human beings
Premium Greek mythology Apollo Allergy
[2010] [Bangladesh Economy: A SWOT Analysis] Course Title: HRM 501 Submitted to: Lieutenant General Mohd. Aminul Karim MBA Program BRAC University Prepared by: Nushrat Sharmin ID # 09264022 MBA Program Summer 2010 Semester Introduction This paper aims to examine Bangladesh’s overall economy with special focus on strengths‚ weaknesses‚ opportunities‚ threats (SWOT) analysis. The research has found that Bangladesh is going to encounter series of economic hurdles in near future. Over the last
Premium Economics Economy
Industry Analysis: Pharmaceutical Preparations Macro and Micro Analysis Macro & Micro Industry Analysis: Pharmaceuticals subgroup: Pharmaceutical preparations The report analyses the macro and micro-environmental factors of the industrial group called “Manufacture of pharmaceutical preparations” with the standard industrial code of 21200‚ according to the most recent version of the UK Standard Industrial Classification (SIC) of 2007. (Office for National Statistics‚ 2007) Although different
Premium Pharmaceutical industry Novartis
Domestic drug manufacturers have cast their eyes overseas for growth and four of them have received the certificate of pharmaceutical product (CPP)‚ one of the pre-requisites for obtaining an export licence from the Department of Drug Administration (DDA). According to the DDA‚ Lomus Pharmaceuticals‚ Deurali-Janata Pharmaceuticals‚ Elder Pharmaceuticals and National Health Care Nepal have received the CPP. The CPP is a must for drug manufacturers wanting to export their products. Once the CPP has
Premium Pharmacology Pharmaceutical drug Drug
Major firms of the world pharmaceutical industry Pharmaceutical industry is characterized by high level of concentration. There are about dozen of multinational companies that dominate in industry. Most of companies are not widely diversified and more than 50% of revenues come from sales of pharmaceutical products. There are few companies in industry that have other large sources of income‚ for example Johnson & Johnson. The pharmaceutical industry has two distinct functions:
Premium Pharmaceutical industry Pharmacology Generic drug
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
Research on Pharmaceutical Channel Distribution 2013 Medhad Nasser Chowdhury 082735530 4/30/2013 MKT 450.1 Faculty Members: Shahed Hussain The New Era A journey through the pharmaceutical channel system in Bangladesh Abstract The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in
Premium Marketing Pharmaceutical industry Supply chain
Bangladesh Small and Cottage Industries Corporation (BSCIC) provides a package of services to private sector entrepreneurs in Bangladesh in the small and cottage industries sector. It was created through an Act of Parliament in 1957 which was later amended in 1992. BSCIC has developed a total of 74 industrial estates throughout the country to foster the growth of SCIs in a balanced manner and also construction works for good number of estates including special type like Tannery‚ API (Active Pharmaceutical
Premium Industry Bangladesh Bengal